Annual Drug Patent Expirations for AVEED
Aveed is a drug marketed by Endo Pharms Inc and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for AVEED.
This drug has forty-eight patent family members in thirty-eight countries.
The generic ingredient in AVEED is testosterone undecanoate. One supplier is listed for this compound. Additional details are available on the testosterone undecanoate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
